首页> 外国专利> METHODS FOR THE MATURATION OF CARDIOMYOCYTES ON AMNIOTIC FLUID CELL-DERIVED ECM, CELLULAR CONSTRUCTS, AND USES FOR CARDIOTOXICITY AND PROARRHYTHMIC SCREENING OF DRUG COMPOUNDS

METHODS FOR THE MATURATION OF CARDIOMYOCYTES ON AMNIOTIC FLUID CELL-DERIVED ECM, CELLULAR CONSTRUCTS, AND USES FOR CARDIOTOXICITY AND PROARRHYTHMIC SCREENING OF DRUG COMPOUNDS

机译:羊膜细胞衍生的ECM,细胞结构上的心肌细胞的成熟方法以及用于药物抗氧性和血友病性筛查的方法

摘要

Disclosed herein are methods of using a cell-derived extracellular matrix derived in-vitro from cells isolated from amniotic fluid (AFC-ECM) for the maturation of immature cardiomyocytes derived from human induced pluripotent stem cells (immature hiPSC-CMs) in culture forming mature cardiomyocytes. Also disclosed herein is a cell construct comprising a monolayer of these mature cardiomyocytes on an AFC-ECM useful for cardiotoxicity and/or proarrhythmic screening assays of drug compounds. Also disclosed herein are methods for determining the cardiotoxicity and/or proarrhythmic effect of a drug compound in vitro using such cell constructs.
机译:本文公开了使用从羊水分离的细胞(AFC-ECM)衍生的源自细胞的细胞外基质体外成熟源自人诱导的多能干细胞(未成熟​​的hiPSC)的不成熟心肌细胞的方法。 -CMs)培养形成成熟的心肌细胞。本文还公开了一种细胞构建体,其在AFC-ECM上包含这些成熟心肌细胞的单层,可用于药物化合物的心脏毒性和/或心律失常筛选测定。本文还公开了使用此类细胞构建体确定药物化合物的体外心脏毒性和/或心律失常作用的方法。

著录项

  • 公开/公告号WO2020172589A1

    专利类型

  • 公开/公告日2020-08-27

    原文格式PDF

  • 申请/专利权人 STEMBIOSYS INC.;

    申请/专利号WO2020US19311

  • 申请日2020-02-21

  • 分类号C12N5/077;C12N5/073;C12N5/0735;

  • 国家 WO

  • 入库时间 2022-08-21 11:09:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号